Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanna Brands is a life sciences company focused on the development and commercialization of cannabinoid-based therapeutic products. The company is primarily recognized for its Sanna Sleep line, which utilizes proprietary formulations of cannabinoids and terpenes to target sleep disorders and insomnia. In 2020, the company was acquired by Hollister Biosciences, which later rebranded as Lobe Sciences, to expand its portfolio of wellness and transformative medicines. Sanna Brands emphasizes a science-driven approach to botanical medicine, aiming to provide non-habit-forming alternatives to traditional sleep aids. Its products are designed to interact with the human endocannabinoid system to promote physiological balance and improved health outcomes. The brand continues to operate as a key component of its parent company's consumer healthcare strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanna Brands.